Overview
- Polen reports a Q1 2026 return of 3.3% gross and 3.0% net, topping the Russell 2000 Growth Index, which fell 2.8%.
- Argan led results after strong earnings and a backlog nearing $3 billion tied to power plants for data centers, with shares at $719.92 and a $10.05 billion market value as of May 13.
- Powell Industries and Bloom Energy also aided relative performance, reflecting demand tied to power and energy projects.
- GeneDx fell despite improving revenue and profitability as uneven test volumes and reimbursement questions weighed on sentiment, with shares at $38.94 and a $1.16 billion market value.
- Alphatec slid on company and sector pressures even as Q1 revenue rose 14% to $192 million with surgical revenue up 17%, and its shares closed at $7.55.